Global Opioid-Induced Constipation Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Opioid-Induced Constipation Market was valued at $3.1 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.5% CAGR, to an estimated market size of $4.2 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global opioid-induced constipation (OIC) market comprises pharmaceutical therapies and targeted medications, such as peripherally acting mu-opioid receptor antagonists (PAMORAs), designed to treat gastrointestinal dysfunction resulting from the use of opioid analgesics for chronic non-cancer and cancer-related pain.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Opioid-Induced Constipation Market in the period 2025-30:
- The high prevalence of OIC, affecting up to 80% of chronic opioid users, ensures a persistent and growing clinical demand for specialized treatments.
- There is a significant market shift from conventional OTC laxatives toward targeted PAMORA therapies that address the root cause of opioid-mediated GI inhibition.
- The aging global population is driving an increase in chronic pain conditions, leading to higher long-term opioid utilization and subsequent OIC cases.
- New institutional mandates in hospital settings are requiring prophylactic bowel regimens to be initiated within 24 hours of the first opioid dose.
- The development of combination formulations that integrate opioids with constipation-mitigating agents is expected to enhance patient adherence and safety.
- The Asia Pacific region is witnessing rapid growth due to the harmonization of clinical guidelines and increased access to advanced pain management therapies.
- Integration of digital therapeutics and monitoring apps is helping clinicians better track bowel function and optimize dosage for refractory OIC cases.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia Pacific
- Rest of World
Segments
- PAMORAs
- Chloride Channel Activators
- Conventional Laxatives & Others